TISOTUMAB VEDOTIN

TISOTUMAB VEDOTIN was reported 971 times

TISOTUMAB VEDOTIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLEPHAROSYNECHIA 2 0.2222
1 SUBCONJUNCTIVAL FIBROSIS 2 0.1818
2 CERVIX CARCINOMA RECURRENT 16 0.0899
3 MYOMETRITIS 1 0.0769
4 CLEAR CELL CARCINOMA OF CERVIX 1 0.0769
5 ASCENDING FLACCID PARALYSIS 2 0.0741
6 CERVIX CANCER METASTATIC 12 0.0727
7 OIL ACNE 1 0.0625
8 VULVAL CANCER STAGE I 1 0.0625
9 TATTOO ASSOCIATED SKIN REACTION 1 0.0435
10 URINARY BLADDER HAEMATOMA 1 0.0370
11 SOLID ORGAN TRANSPLANT REJECTION 1 0.0357
12 SYMBLEPHARON 9 0.0345
13 ALLERGIC KERATITIS 1 0.0333
14 KERATOLYSIS EXFOLIATIVA ACQUIRED 1 0.0312
15 CONJUNCTIVAL ULCER 4 0.0290
16 SQUAMOUS CELL CARCINOMA OF THE CERVIX 6 0.0270
17 CORNEAL EPITHELIOPATHY 1 0.0263
18 ADENOCARCINOMA OF THE CERVIX 4 0.0247
19 OCULAR TOXICITY 24 0.0217
20 CONJUNCTIVAL SCAR 3 0.0199
21 CONJUNCTIVAL EROSION 2 0.0165
22 CONJUNCTIVAL CYST 1 0.0156
23 CYSTITIS RADIATION 3 0.0155
24 INFECTIVE KERATITIS 1 0.0141
25 TRICHIASIS 4 0.0126
26 PUNCTATE KERATITIS 11 0.0120
27 MEIBOMIANITIS 1 0.0111
28 VIRAL UVEITIS 1 0.0103
29 CORNEAL CYST 1 0.0103
30 BLADDER TAMPONADE 3 0.0099
31 HERPES DERMATITIS 2 0.0099
32 INVESTIGATION NONCOMPLIANCE 1 0.0092
33 CORNEAL TOXICITY 1 0.0090
34 TUMOUR INFLAMMATION 1 0.0089
35 OBSTRUCTIVE NEPHROPATHY 1 0.0081
36 CORNEAL NEOVASCULARISATION 2 0.0081
37 KERATITIS 22 0.0072
38 CERVIX CARCINOMA STAGE IV 1 0.0069
39 PERIPHERAL MOTOR NEUROPATHY 9 0.0064
40 ULCERATIVE KERATITIS 17 0.0062
41 GASTROENTERITIS RADIATION 2 0.0061
42 NEPHROSTOMY 2 0.0061
43 CORNEAL SCAR 3 0.0060
44 ECTROPION 2 0.0059
45 SOFT TISSUE INFLAMMATION 2 0.0059
46 EYE ULCER 3 0.0052
47 CERVIX CARCINOMA 20 0.0051
48 STRESS ULCER 1 0.0051
49 CORNEAL INFECTION 1 0.0046
50 LASER THERAPY 1 0.0044
51 MEIBOMIAN GLAND DYSFUNCTION 2 0.0044
52 OPTIC DISC HAEMORRHAGE 1 0.0044
53 ACUTE MOTOR-SENSORY AXONAL NEUROPATHY 1 0.0043
54 PRODUCT TEMPERATURE EXCURSION ISSUE 22 0.0043
55 SEVERE CUTANEOUS ADVERSE REACTION 1 0.0042
56 TUMOUR INVASION 2 0.0041
57 TOXIC ERYTHEMA OF CHEMOTHERAPY 1 0.0039
58 OSCILLOPSIA 1 0.0039
59 CONJUNCTIVITIS VIRAL 1 0.0038
60 CORNEAL EROSION 2 0.0037
61 ATOPY 1 0.0036
62 OCULAR SURFACE DISEASE 1 0.0036
63 VULVAL ULCERATION 1 0.0035
64 EYELID THICKENING 1 0.0035
65 EYE INFECTION STAPHYLOCOCCAL 1 0.0035
66 CORNEAL EPITHELIUM DEFECT 2 0.0034
67 CORNEAL LESION 1 0.0032
68 VULVAL DISORDER 2 0.0030
69 GASTROINTESTINAL POLYP 1 0.0030
70 PNEUMONITIS CHEMICAL 1 0.0029
71 CONJUNCTIVITIS 52 0.0028
72 VAGINAL FISTULA 1 0.0028
73 CORNEAL DISORDER 6 0.0027
74 ANISOCORIA 1 0.0026
75 CONJUNCTIVAL DISORDER 1 0.0026
76 CREATINE KINASE INCREASED 2 0.0026
77 BLADDER PERFORATION 1 0.0026
78 URINARY BLADDER HAEMORRHAGE 5 0.0024
79 URINARY TRACT INFECTION STAPHYLOCOCCAL 1 0.0023
80 CONJUNCTIVAL HYPERAEMIA 8 0.0022
81 ENTEROCOLITIS INFECTIOUS 2 0.0022
82 LACRIMATION DECREASED 1 0.0021
83 METASTASES TO PERITONEUM 5 0.0020
84 METASTATIC SQUAMOUS CELL CARCINOMA 1 0.0020
85 FAECAL VOLUME INCREASED 1 0.0019
86 INFUSION SITE VESICLES 1 0.0019
87 INTRAOCULAR PRESSURE DECREASED 1 0.0019
88 HEART FAILURE WITH REDUCED EJECTION FRACTION 1 0.0019
89 RECTAL PERFORATION 1 0.0019
90 NEUROLOGIC NEGLECT SYNDROME 1 0.0018
91 EYE INFECTION BACTERIAL 1 0.0018
92 VULVOVAGINAL INJURY 1 0.0018
93 INTERCEPTED MEDICATION ERROR 8 0.0017
94 VULVAL CANCER 1 0.0017
95 CAMPYLOBACTER GASTROENTERITIS 1 0.0017
96 CORNEAL PERFORATION 1 0.0016
97 ANION GAP 1 0.0016
98 CHALAZION 1 0.0016
99 INTESTINAL ANASTOMOSIS 1 0.0016
100 NASAL CRUSTING 1 0.0015
101 HERPES OPHTHALMIC 2 0.0015
102 ENDOMETRITIS 1 0.0015
103 TUMOUR FLARE 1 0.0015
104 CORNEAL OPACITY 2 0.0015
105 ORAL FUNGAL INFECTION 4 0.0015
106 CORNEAL ABRASION 2 0.0015
107 POSITRON EMISSION TOMOGRAM ABNORMAL 1 0.0014
108 SJS-TEN OVERLAP 1 0.0014
109 SMEAR CERVIX ABNORMAL 2 0.0014
110 OVARIAN MASS 1 0.0014
111 MALIGNANT ASCITES 1 0.0013
112 STOMACH MASS 1 0.0013
113 KERATOPATHY 2 0.0013
114 PRODUCT CONFUSION 1 0.0013
115 CYSTITIS HAEMORRHAGIC 5 0.0012
116 ACNE PUSTULAR 1 0.0012
117 PAPILLOMA VIRAL INFECTION 2 0.0012
118 FEMALE GENITAL TRACT FISTULA 2 0.0012
119 PROTEIN URINE 1 0.0011
120 DRY EYE 55 0.0011
121 EYE DISCHARGE 11 0.0011
122 CORRECTIVE LENS USER 1 0.0010
123 MUCOSAL DISORDER 1 0.0010
124 IMMUNE-MEDIATED DERMATITIS 1 0.0010
125 BUTTERFLY RASH 1 0.0010
126 CONJUNCTIVAL OEDEMA 1 0.0010
127 EYE DISORDER 31 0.0009
128 HOSPICE CARE 9 0.0009
129 SUSPECTED OFF LABEL USE 4 0.0009
130 HALO VISION 1 0.0009
131 NEPHROGENIC DIABETES INSIPIDUS 1 0.0009
132 RECTAL ULCER 1 0.0009
133 SENSE OF OPPRESSION 1 0.0008
134 NEUROPATHY PERIPHERAL 79 0.0008
135 CLOSTRIDIUM COLITIS 1 0.0008
136 EYE OEDEMA 2 0.0008
137 LARGE INTESTINE INFECTION 1 0.0008
138 FRACTURED COCCYX 1 0.0008
139 CANCER PAIN 2 0.0008
140 MALIGNANT NEOPLASM PROGRESSION 80 0.0008
141 TRANSITIONAL CELL CARCINOMA 1 0.0008
142 RETINAL DEGENERATION 1 0.0008
143 HYPOVITAMINOSIS 1 0.0008
144 BLEPHARITIS 3 0.0007
145 GASTRIC PERFORATION 2 0.0007
146 EXTRAVASATION 3 0.0007
147 INFUSION SITE RASH 1 0.0007
148 JOINT INSTABILITY 1 0.0007
149 PRERENAL FAILURE 1 0.0007
150 TUMOUR HAEMORRHAGE 2 0.0007
151 CEREBELLAR HAEMORRHAGE 1 0.0007
152 ENTEROCOLITIS 4 0.0007
153 NONINFECTIVE GINGIVITIS 1 0.0007
154 NORMOCYTIC ANAEMIA 1 0.0007
155 CONJUNCTIVITIS ALLERGIC 1 0.0007
156 GENITAL HERPES 1 0.0007
157 ORAL MUCOSAL ERUPTION 1 0.0007
158 INFUSION SITE EXTRAVASATION 4 0.0006
159 MEGACOLON 1 0.0006
160 SCLERITIS 1 0.0006
161 OCULAR DISCOMFORT 7 0.0006
162 FOOD AVERSION 1 0.0006
163 BLADDER NEOPLASM 1 0.0006
164 JUGULAR VEIN THROMBOSIS 1 0.0006
165 FAECALOMA 3 0.0005
166 PUPILLARY REFLEX IMPAIRED 1 0.0005
167 HYDRONEPHROSIS 4 0.0005
168 SMALL INTESTINAL PERFORATION 1 0.0005
169 SKIN TOXICITY 3 0.0005
170 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
171 RADIOTHERAPY 1 0.0005
172 DIPLEGIA 1 0.0005
173 SMALL INTESTINAL HAEMORRHAGE 1 0.0005
174 EAR HAEMORRHAGE 1 0.0005
175 RECURRENT CANCER 2 0.0005
176 DERMATITIS PSORIASIFORM 1 0.0005
177 RADIATION PNEUMONITIS 1 0.0005
178 VAGINAL HAEMORRHAGE 20 0.0005
179 ILEUS PARALYTIC 2 0.0004
180 LARGE INTESTINAL OBSTRUCTION 1 0.0004
181 READING DISORDER 1 0.0004
182 EYELID DISORDER 1 0.0004
183 PERFORMANCE STATUS DECREASED 2 0.0004
184 SKIN TIGHTNESS 2 0.0004
185 PUSTULE 1 0.0004
186 URINARY TRACT OBSTRUCTION 1 0.0004
187 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
188 GASTROINTESTINAL TOXICITY 2 0.0004
189 DIABETES INSIPIDUS 1 0.0004
190 GUILLAIN-BARRE SYNDROME 2 0.0004
191 TRANSPLANT FAILURE 1 0.0004
192 RETINAL TEAR 1 0.0004
193 SYSTEMIC CANDIDA 1 0.0004
194 DERMATOMYOSITIS 1 0.0004
195 HAEMORRHAGE URINARY TRACT 1 0.0004
196 CACHEXIA 2 0.0004
197 EPISTAXIS 29 0.0004
198 PROCTITIS 1 0.0004
199 INFUSION SITE ERYTHEMA 3 0.0004
200 PERONEAL NERVE PALSY 2 0.0004
201 EYELID MARGIN CRUSTING 1 0.0003
202 THORACIC VERTEBRAL FRACTURE 1 0.0003
203 METABOLIC ENCEPHALOPATHY 1 0.0003
204 BONE MARROW DISORDER 1 0.0003
205 EMBOLISM VENOUS 1 0.0003
206 DERMATITIS ACNEIFORM 2 0.0003
207 CHOLANGITIS 2 0.0003
208 HAEMATURIA 11 0.0003
209 NEOPLASM PROGRESSION 11 0.0003
210 NON-CARDIAC CHEST PAIN 1 0.0003
211 STEVENS-JOHNSON SYNDROME 7 0.0003
212 EYE INFLAMMATION 3 0.0003
213 BILE DUCT STONE 1 0.0003
214 PROCTALGIA 2 0.0003
215 WALKING AID USER 2 0.0003
216 RECTAL HAEMORRHAGE 13 0.0003
217 METASTASES TO SPINE 1 0.0003
218 METASTASES TO LYMPH NODES 2 0.0003
219 WRONG PRODUCT ADMINISTERED 2 0.0003
220 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
221 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
222 LYMPHOEDEMA 2 0.0003
223 WEIGHT FLUCTUATION 3 0.0003
224 JAUNDICE CHOLESTATIC 1 0.0003
225 SKIN WEEPING 1 0.0003
226 METASTASIS 2 0.0003
227 OCULAR HYPERAEMIA 13 0.0003
228 SEBORRHOEA 1 0.0003
229 IMMUNE-MEDIATED ENTEROCOLITIS 1 0.0003
230 FEBRILE NEUTROPENIA 18 0.0003
231 CATHETER SITE INFECTION 1 0.0003
232 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
233 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
234 SPINAL CORD COMPRESSION 1 0.0003
235 PROCEDURAL HAEMORRHAGE 1 0.0003
236 CYTOPENIA 3 0.0002
237 PERIPHERAL ISCHAEMIA 1 0.0002
238 SMALL INTESTINAL OBSTRUCTION 3 0.0002
239 HYPERURICAEMIA 1 0.0002
240 GASTROINTESTINAL PERFORATION 1 0.0002
241 SECOND PRIMARY MALIGNANCY 2 0.0002
242 ABNORMAL SENSATION IN EYE 1 0.0002
243 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
244 HORDEOLUM 1 0.0002
245 SKIN SWELLING 2 0.0002
246 ORAL CANDIDIASIS 3 0.0002
247 TUMOUR LYSIS SYNDROME 2 0.0002
248 BLOOD CREATINE INCREASED 1 0.0002
249 WHEELCHAIR USER 1 0.0002
250 MYOSITIS 2 0.0002
251 PNEUMONITIS 6 0.0002
252 PRODUCT DISTRIBUTION ISSUE 2 0.0002
253 HYPOMAGNESAEMIA 3 0.0002
254 APHONIA 3 0.0002
255 UMBILICAL HERNIA 1 0.0002
256 YELLOW SKIN 1 0.0002
257 SKIN ABRASION 1 0.0002
258 NON-SMALL CELL LUNG CANCER 1 0.0002
259 HYPOVOLAEMIC SHOCK 1 0.0002
260 TUMOUR MARKER INCREASED 1 0.0002
261 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
262 RENAL TUBULAR NECROSIS 2 0.0002
263 CATARACT 12 0.0002
264 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
265 HYPOKALAEMIA 9 0.0002
266 HYPERGLYCAEMIA 7 0.0002
267 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
268 HEPATIC FUNCTION ABNORMAL 7 0.0002
269 LIVER FUNCTION TEST INCREASED 4 0.0002
270 ANAEMIA 35 0.0002
271 EYE PRURITUS 6 0.0002
272 EYE PAIN 10 0.0002
273 EYE INFECTION 2 0.0002
274 METABOLIC DISORDER 1 0.0002
275 ELECTROLYTE IMBALANCE 2 0.0002
276 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
277 METASTASES TO LIVER 3 0.0002
278 CATARACT OPERATION 1 0.0002
279 PROTHROMBIN TIME PROLONGED 1 0.0002
280 DIABETIC KETOACIDOSIS 4 0.0002
281 INJECTION SITE VESICLES 1 0.0002
282 PIGMENTATION DISORDER 1 0.0002
283 INTESTINAL OBSTRUCTION 6 0.0002
284 INFUSION SITE SWELLING 1 0.0002
285 HYPOCALCAEMIA 3 0.0002
286 FRACTURE 3 0.0002
287 ENTERITIS 1 0.0002
288 INFUSION SITE PAIN 2 0.0002
289 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
290 PRODUCT PREPARATION ISSUE 1 0.0002
291 DYSGRAPHIA 1 0.0002
292 VIRAL INFECTION 5 0.0002
293 POST-TRAUMATIC STRESS DISORDER 1 0.0001
294 STOMATITIS 9 0.0001
295 ULCER HAEMORRHAGE 1 0.0001
296 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
297 NEUTROPHIL COUNT DECREASED 6 0.0001
298 INTERSTITIAL LUNG DISEASE 7 0.0001
299 HYPERTRANSAMINASAEMIA 1 0.0001
300 SKIN REACTION 2 0.0001
301 DUODENAL ULCER 1 0.0001
302 MUSCULAR WEAKNESS 16 0.0001
303 RETINAL HAEMORRHAGE 1 0.0001
304 HYPERTHYROIDISM 2 0.0001
305 GASTROENTERITIS 2 0.0001
306 THERAPY CESSATION 7 0.0001
307 HYPOPHOSPHATAEMIA 1 0.0001
308 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
309 PULMONARY MASS 2 0.0001
310 SUNBURN 1 0.0001
311 KETOACIDOSIS 1 0.0001
312 TROPONIN INCREASED 1 0.0001
313 PULMONARY HAEMORRHAGE 1 0.0001
314 GASTROINTESTINAL INFLAMMATION 1 0.0001
315 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
316 ALOPECIA 25 0.0001
317 HAEMATOCHEZIA 7 0.0001
318 GINGIVAL PAIN 1 0.0001
319 UTERINE CANCER 1 0.0001
320 MYASTHENIA GRAVIS 1 0.0001
321 EYE IRRITATION 7 0.0001
322 VISUAL ACUITY REDUCED 4 0.0001
323 EMBOLISM 1 0.0001
324 EOSINOPHIL COUNT INCREASED 1 0.0001
325 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
326 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
327 HEPATITIS 3 0.0001
328 SKIN HYPERPIGMENTATION 1 0.0001
329 MYOPATHY 1 0.0001
330 PYELONEPHRITIS 1 0.0001
331 HAEMORRHAGE 12 0.0001
332 GRIP STRENGTH DECREASED 1 0.0001
333 IMMUNOSUPPRESSION 1 0.0001
334 DRUG ERUPTION 2 0.0001
335 FACIAL PAIN 1 0.0001
336 OROPHARYNGEAL DISCOMFORT 1 0.0001
337 VISION BLURRED 15 0.0001
338 PNEUMONIA BACTERIAL 1 0.0001
339 BRAIN NEOPLASM 1 0.0001
340 SKIN DISCOLOURATION 5 0.0001
341 MENTAL STATUS CHANGES 3 0.0001
342 RASH 47 0.0001
343 HEPATIC STEATOSIS 2 0.0001
344 ERYTHEMA MULTIFORME 1 0.0001
345 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
346 FLANK PAIN 1 0.0001
347 HYPONATRAEMIA 6 0.0001
348 PHOTOPHOBIA 2 0.0001
349 COLITIS 4 0.0001
350 BLOOD URINE PRESENT 2 0.0001
351 RECALLED PRODUCT ADMINISTERED 1 0.0001
352 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
353 ACUTE KIDNEY INJURY 16 0.0001
354 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
355 THROMBOTIC MICROANGIOPATHY 1 0.0001
356 ASCITES 3 0.0001
357 LABORATORY TEST ABNORMAL 3 0.0001
358 CYTOKINE RELEASE SYNDROME 2 0.0001
359 VAGINAL DISCHARGE 1 0.0001
360 FEEDING DISORDER 2 0.0001
361 TASTE DISORDER 2 0.0001
362 BLINDNESS 4 0.0001
363 MOTOR DYSFUNCTION 1 0.0001
364 EAR DISCOMFORT 1 0.0001
365 CONSTIPATION 21 0.0001
366 TRANSFUSION 1 0.0001
367 FULL BLOOD COUNT ABNORMAL 1 0.0001
368 SUDDEN DEATH 1 0.0001
369 RETCHING 2 0.0001
370 WEIGHT DECREASED 26 0.0001
371 PRODUCT DISPENSING ERROR 2 0.0001
372 OESOPHAGITIS 1 0.0001
373 GASTROINTESTINAL PAIN 1 0.0001
374 MELAENA 2 0.0001
375 SKIN DISORDER 3 0.0001
376 NERVE INJURY 1 0.0001
377 RASH MACULO-PAPULAR 2 0.0001
378 SKIN INFECTION 1 0.0001
379 PANCREATITIS ACUTE 2 0.0001
380 FISTULA 1 0.0001
381 GAIT DISTURBANCE 17 0.0001
382 VISUAL IMPAIRMENT 11 0.0001
383 CHROMATURIA 2 0.0001
384 NEUTROPENIA 12 0.0001
385 IMPAIRED DRIVING ABILITY 1 0.0001
386 DERMATITIS CONTACT 1 0.0001
387 INTERNAL HAEMORRHAGE 1 0.0001
388 METASTASES TO LUNG 1 0.0001
389 EYELID OEDEMA 1 0.0001
390 MACULAR DEGENERATION 1 0.0001
391 RASH ERYTHEMATOUS 4 0.0001
392 NAUSEA 66 0.0001
393 MYELOSUPPRESSION 3 0.0001
394 DEHYDRATION 11 0.0001
395 C-REACTIVE PROTEIN INCREASED 3 0.0001
396 NOCTURIA 1 0.0001
397 ABDOMINAL PAIN 19 0.0001
398 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
399 INTERCEPTED PRODUCT PREPARATION ERROR 1 0.0001
400 HYPERCALCAEMIA 1 0.0001
401 GENERALISED OEDEMA 1 0.0001
402 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
403 THROMBOCYTOPENIA 9 0.0001
404 ILEUS 1 0.0001
405 ABDOMINAL PAIN LOWER 2 0.0001
406 INTRAOCULAR PRESSURE INCREASED 1 0.0001
407 ROTATOR CUFF SYNDROME 1 0.0001
408 GENITAL HAEMORRHAGE 1 0.0001
409 SKIN ULCER 2 0.0001
410 MUCOSAL INFLAMMATION 2 0.0001
411 BEDRIDDEN 1 0.0001
412 GASTRITIS 2 0.0001
413 IMMUNE SYSTEM DISORDER 1 0.0001
414 EYE HAEMORRHAGE 1 0.0001
415 FEAR 2 0.0001
416 SINUS CONGESTION 1 0.0001
417 GINGIVAL BLEEDING 1 0.0001
418 SKIN LESION 2 0.0001
419 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
420 PANCYTOPENIA 4 0.0001
421 BLISTER 4 0.0001
422 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
423 SEASONAL ALLERGY 1 0.0001
424 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
425 PARALYSIS 1 0.0001
426 HYPERSOMNIA 2 0.0001
427 MOBILITY DECREASED 5 0.0001
428 PYREXIA 24 0.0001
429 MYELODYSPLASTIC SYNDROME 1 0.0001
430 DECREASED APPETITE 16 0.0001
431 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
432 HEPATIC FAILURE 2 0.0001
433 LACRIMATION INCREASED 2 0.0001
434 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
435 PLATELET COUNT DECREASED 7 0.0001
436 URINARY TRACT INFECTION 11 0.0001
437 THERAPY PARTIAL RESPONDER 1 0.0001
438 BRAIN FOG 1 0.0001
439 PRODUCT USE COMPLAINT 1 0.0001
440 RESPIRATORY TRACT CONGESTION 1 0.0001
441 CYSTITIS 2 0.0001
442 OBESITY 1 0.0001
443 SEPSIS 7 0.0001
444 SCIATICA 1 0.0001
445 SENSORY DISTURBANCE 1 0.0001
446 MOVEMENT DISORDER 2 0.0001
447 DIARRHOEA 40 0.0001
448 SWELLING FACE 4 0.0001
449 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
450 CYTOMEGALOVIRUS INFECTION 1 0.0001
451 COAGULOPATHY 1 0.0001
452 URINARY RETENTION 2 0.0001
453 CELLULITIS 3 0.0001
454 FACE OEDEMA 1 0.0001
455 SKIN EXFOLIATION 5 0.0001
456 HEPATIC ENZYME INCREASED 4 0.0001
457 SCAR 1 0.0001
458 MALAISE 25 0.0001
459 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
460 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
461 CEREBRAL HAEMORRHAGE 2 0.0001
462 RASH PRURITIC 3 0.0001
463 VOMITING 26 0.0001
464 PELVIC PAIN 1 0.0001
465 BONE DISORDER 1 0.0001
466 RESPIRATORY FAILURE 4 0.0001
467 HYPOAESTHESIA 8 0.0001
468 DYSPNOEA EXERTIONAL 2 0.0001
469 BLOOD SODIUM DECREASED 1 0.0001
470 ACNE 4 0.0001
471 PROTEINURIA 1 0.0001
472 DYSPHONIA 3 0.0001
473 HAEMORRHOIDS 1 0.0001
474 NASAL CONGESTION 3 0.0001
475 KIDNEY INFECTION 1 0.0001
476 SINUS DISORDER 1 0.0001
477 PLEURAL EFFUSION 3 0.0000
478 HAEMOGLOBIN DECREASED 5 0.0000
479 PERITONITIS 1 0.0000
480 PULMONARY HYPERTENSION 1 0.0000
481 OFF LABEL USE 42 0.0000
482 DERMATITIS 1 0.0000
483 RENAL IMPAIRMENT 4 0.0000
484 DEATH 40 0.0000
485 RHINORRHOEA 3 0.0000
486 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
487 SEPTIC SHOCK 2 0.0000
488 BLOOD CREATININE INCREASED 3 0.0000
489 PRODUCT PRESCRIBING ISSUE 1 0.0000
490 INFUSION RELATED REACTION 3 0.0000
491 LIVER DISORDER 2 0.0000
492 TOOTH DISORDER 1 0.0000
493 RASH PAPULAR 1 0.0000
494 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
495 THERAPY NON-RESPONDER 2 0.0000
496 FATIGUE 34 0.0000
497 SHOCK 1 0.0000
498 MUSCLE TWITCHING 1 0.0000
499 PERICARDIAL EFFUSION 1 0.0000
500 BURNING SENSATION 3 0.0000
501 DISEASE PROGRESSION 5 0.0000
502 DISEASE RECURRENCE 2 0.0000
503 NEURALGIA 1 0.0000
504 OEDEMA PERIPHERAL 5 0.0000
505 LIVER INJURY 1 0.0000
506 ENCEPHALOPATHY 1 0.0000
507 PNEUMONIA 13 0.0000
508 CONDITION AGGRAVATED 12 0.0000
509 HAEMATEMESIS 1 0.0000
510 FLUSHING 4 0.0000
511 ANAPHYLACTIC SHOCK 1 0.0000
512 DIPLOPIA 1 0.0000
513 DEAFNESS 1 0.0000
514 PANCREATITIS 2 0.0000
515 BLOOD BILIRUBIN INCREASED 1 0.0000
516 THROAT TIGHTNESS 1 0.0000
517 PALLOR 1 0.0000
518 RESPIRATORY ARREST 1 0.0000
519 FALL 12 0.0000
520 FEELING COLD 1 0.0000
521 HAEMOPTYSIS 1 0.0000
522 WEIGHT INCREASED 8 0.0000
523 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
524 RED BLOOD CELL COUNT DECREASED 1 0.0000
525 BALANCE DISORDER 3 0.0000
526 LIVER FUNCTION TEST ABNORMAL 1 0.0000
527 DYSSTASIA 1 0.0000
528 BONE PAIN 2 0.0000
529 TACHYCARDIA 3 0.0000
530 BLOOD POTASSIUM DECREASED 1 0.0000
531 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
532 ADVERSE EVENT 3 0.0000
533 HOSPITALISATION 5 0.0000
534 PERIPHERAL SWELLING 5 0.0000
535 NERVOUS SYSTEM DISORDER 1 0.0000
536 METABOLIC ACIDOSIS 1 0.0000
537 LACTIC ACIDOSIS 1 0.0000
538 FUNGAL INFECTION 1 0.0000
539 GAIT INABILITY 1 0.0000
540 MYALGIA 5 0.0000
541 ILLNESS 3 0.0000
542 DELIRIUM 1 0.0000
543 PRURITUS 11 0.0000
544 HYPERKALAEMIA 1 0.0000
545 HYPOXIA 1 0.0000
546 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
547 PANIC ATTACK 1 0.0000
548 DYSURIA 1 0.0000
549 EYE SWELLING 1 0.0000
550 ASTHENIA 10 0.0000
551 DYSARTHRIA 1 0.0000
552 HOT FLUSH 2 0.0000
553 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
554 THROMBOSIS 2 0.0000
555 PAIN 15 0.0000
556 ERYTHEMA 5 0.0000
557 TREATMENT FAILURE 2 0.0000
558 TREMOR 4 0.0000
559 MUSCULOSKELETAL STIFFNESS 2 0.0000
560 RENAL FAILURE 3 0.0000
561 COLITIS ULCERATIVE 1 0.0000
562 TINNITUS 1 0.0000
563 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
564 OROPHARYNGEAL PAIN 2 0.0000
565 RENAL DISORDER 1 0.0000
566 SWELLING 2 0.0000
567 PULMONARY EMBOLISM 2 0.0000
568 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
569 HYPOGLYCAEMIA 1 0.0000
570 PAIN IN EXTREMITY 6 0.0000
571 LEUKOPENIA 1 0.0000
572 ECZEMA 1 0.0000
573 SPEECH DISORDER 1 0.0000
574 PARAESTHESIA 3 0.0000
575 CONFUSIONAL STATE 3 0.0000
576 OEDEMA 1 0.0000
577 ANAPHYLACTIC REACTION 1 0.0000
578 NECK PAIN 1 0.0000
579 OXYGEN SATURATION DECREASED 1 0.0000
580 PRODUCT SUBSTITUTION ISSUE 1 0.0000
581 CHILLS 2 0.0000
582 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
583 VERTIGO 1 0.0000
584 PRODUCT USE ISSUE 3 0.0000
585 DYSPNOEA 9 0.0000
586 LOSS OF CONSCIOUSNESS 2 0.0000
587 DEEP VEIN THROMBOSIS 1 0.0000
588 AMNESIA 1 0.0000
589 BLOOD PRESSURE DECREASED 1 0.0000
590 HYPOTENSION 3 0.0000
591 ABDOMINAL PAIN UPPER 3 0.0000
592 COUGH 4 0.0000
593 THERAPY INTERRUPTED 1 0.0000
594 SKIN BURNING SENSATION 1 0.0000
595 BRONCHITIS 1 0.0000
596 DYSGEUSIA 1 0.0000
597 HALLUCINATION 1 0.0000
598 DEPRESSION 3 0.0000
599 CARDIAC FAILURE CONGESTIVE 1 0.0000
600 DRY MOUTH 1 0.0000
601 CARDIAC ARREST 1 0.0000
602 ABDOMINAL DISCOMFORT 2 0.0000
603 CEREBROVASCULAR ACCIDENT 2 0.0000
604 INTENTIONAL PRODUCT MISUSE 1 0.0000
605 COVID-19 2 0.0000
606 HEADACHE 7 0.0000
607 GASTROINTESTINAL DISORDER 1 0.0000
608 ADVERSE DRUG REACTION 1 0.0000
609 MUSCLE SPASMS 2 0.0000
610 CHEST PAIN 2 0.0000
611 HYPERSENSITIVITY 2 0.0000
612 CONTUSION 1 0.0000
613 DRUG INTOLERANCE 1 0.0000
614 ATRIAL FIBRILLATION 1 0.0000
615 PRODUCT DOSE OMISSION ISSUE 3 0.0000
616 CHEST DISCOMFORT 1 0.0000
617 ARTHRALGIA 4 0.0000
618 ABDOMINAL DISTENSION 1 0.0000
619 INFLUENZA 1 0.0000
620 RHEUMATOID ARTHRITIS 1 0.0000
621 SEIZURE 1 0.0000
622 JOINT SWELLING 1 0.0000
623 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
624 INJECTION SITE ERYTHEMA 1 0.0000
625 INSOMNIA 2 0.0000
626 DRY SKIN 1 0.0000
627 MEMORY IMPAIRMENT 1 0.0000
628 ANXIETY 2 0.0000
629 INFECTION 1 0.0000
630 DRUG INTERACTION 1 0.0000
631 URTICARIA 1 0.0000
632 NO ADVERSE EVENT 1 0.0000
633 DRUG INEFFECTIVE 7 0.0000
634 SOMNOLENCE 1 0.0000
635 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
636 HYPERTENSION 1 0.0000
637 FEELING ABNORMAL 1 0.0000
638 DIZZINESS 1 0.0000